Hims & Hers Health Inc (HIMS)

$12.34

-0.07

(-0.56%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Hims & Hers Health Inc

  • Increasing Revenue

    Revenue is up for the last 16 quarters, 30.06M → 246.61M (in $), with an average increase of 12.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -7.56M → 1.24M (in $), with an average increase of 707.8% per quarter

  • Vs CL

    In the last 1 year, Colgate-palmolive Co. has given 14.8% return, outperforming this stock by 2.0%

  • Vs PG

    In the last 3 years, Procter & Gamble Company, The has given 7.5% return, outperforming this stock by 6.6%

Performance

  • $12.20
    $12.63
    $12.34
    downward going graph

    1.18%

    Downside

    Day's Volatility :3.44%

    Upside

    2.3%

    downward going graph
  • $5.65
    $16.88
    $12.34
    downward going graph

    54.21%

    Downside

    52 Weeks Volatility :66.53%

    Upside

    26.9%

    downward going graph

Returns

PeriodHims & Hers Health IncSector (Health Care)Index (Russel 2000)
3 Months
47.39%
-0.7%
0.0%
6 Months
102.45%
6.6%
0.0%
1 Year
12.82%
3.7%
-1.5%
3 Years
10.7%
14.0%
-21.8%

Highlights

Market Capitalization
2.7B
Book Value
$1.61
Earnings Per Share (EPS)
-0.11
Wall Street Target Price
15.87
Profit Margin
-2.7%
Operating Margin TTM
1.06%
Return On Assets TTM
-4.03%
Return On Equity TTM
-7.18%
Revenue TTM
872.0M
Revenue Per Share TTM
4.17
Quarterly Revenue Growth YOY
47.5%
Gross Profit TTM
408.7M
EBITDA
-16.5M
Diluted Eps TTM
-0.11
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.05
EPS Estimate Next Year
0.2
EPS Estimate Current Quarter
-0.02
EPS Estimate Next Quarter
-0.03

Analyst Recommendation

Buy
    68%Buy
    31%Hold
    0
    0%Sell
Based on 16 Wall street analysts offering stock ratings for Hims & Hers Health Inc(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
12
Hold
5
5
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 28.61%

Current $12.34
Target $15.87

Company Financials

FY19Y/Y Change
Revenue
82.6M
-
Net Income
-72.1M
-
Net Profit Margin
-87.29%
-
FY20Y/Y Change
Revenue
148.8M
↑ 80.18%
Net Income
-18.1M
↓ 74.86%
Net Profit Margin
-12.18%
↑ 75.11%
FY21Y/Y Change
Revenue
271.9M
↑ 82.77%
Net Income
-107.7M
↑ 494.34%
Net Profit Margin
-39.6%
↓ 27.42%
FY22Y/Y Change
Revenue
526.9M
↑ 93.81%
Net Income
-65.7M
↓ 38.99%
Net Profit Margin
-12.46%
↑ 27.14%
FY23Y/Y Change
Revenue
872.0M
↑ 65.49%
Net Income
-23.5M
↓ 64.15%
Net Profit Margin
-2.7%
↑ 9.76%
Q3 FY22Q/Q Change
Revenue
144.8M
↑ 27.54%
Net Income
-18.8M
↓ 4.26%
Net Profit Margin
-13.01%
↑ 4.32%
Q4 FY22Q/Q Change
Revenue
167.2M
↑ 15.44%
Net Income
-10.9M
↓ 42.11%
Net Profit Margin
-6.52%
↑ 6.49%
Q1 FY23Q/Q Change
Revenue
190.8M
↑ 14.09%
Net Income
-10.1M
↓ 7.7%
Net Profit Margin
-5.28%
↑ 1.24%
Q2 FY23Q/Q Change
Revenue
207.9M
↑ 8.99%
Net Income
-7.2M
↓ 28.91%
Net Profit Margin
-3.44%
↑ 1.84%
Q3 FY23Q/Q Change
Revenue
226.7M
↑ 9.04%
Net Income
-7.6M
↑ 5.73%
Net Profit Margin
-3.34%
↑ 0.1%
Q4 FY23Q/Q Change
Revenue
246.6M
↑ 8.79%
Net Income
1.2M
↓ 116.45%
Net Profit Margin
0.5%
↑ 3.84%
FY19Y/Y Change
Total Assets
72.1M
-
Total Liabilities
207.4M
-
FY20Y/Y Change
Total Assets
118.7M
↑ 64.7%
Total Liabilities
265.6M
↑ 28.07%
FY21Y/Y Change
Total Assets
420.6M
↑ 254.33%
Total Liabilities
86.0M
↓ 67.63%
FY22Y/Y Change
Total Assets
366.3M
↓ 12.9%
Total Liabilities
54.6M
↓ 36.49%
FY23Y/Y Change
Total Assets
441.2M
↑ 20.43%
Total Liabilities
97.2M
↑ 77.94%
Q3 FY22Q/Q Change
Total Assets
382.8M
↑ 0.75%
Total Liabilities
71.9M
↑ 18.02%
Q4 FY22Q/Q Change
Total Assets
366.3M
↓ 4.31%
Total Liabilities
54.6M
↓ 24.04%
Q1 FY23Q/Q Change
Total Assets
376.3M
↑ 2.72%
Total Liabilities
63.6M
↑ 16.41%
Q2 FY23Q/Q Change
Total Assets
389.9M
↑ 3.61%
Total Liabilities
69.8M
↑ 9.84%
Q3 FY23Q/Q Change
Total Assets
413.9M
↑ 6.15%
Total Liabilities
85.3M
↑ 22.19%
Q4 FY23Q/Q Change
Total Assets
441.2M
↑ 6.6%
Total Liabilities
97.2M
↑ 13.9%
FY18Y/Y Change
Operating Cash Flow
-57.3M
-
Investing Cash Flow
-8.0K
-
Financing Cash Flow
78.2M
-
FY19Y/Y Change
Operating Cash Flow
-74.9M
↑ 30.61%
Investing Cash Flow
-39.3M
↑ 491137.5%
Financing Cash Flow
95.3M
↑ 21.97%
FY20Y/Y Change
Operating Cash Flow
-2.5M
↓ 96.69%
Investing Cash Flow
-39.7M
↑ 1.02%
Financing Cash Flow
47.7M
↓ 49.91%
FY21Y/Y Change
Operating Cash Flow
-34.4M
↑ 1288.14%
Investing Cash Flow
-156.3M
↑ 293.61%
Financing Cash Flow
235.0M
↑ 392.32%
FY22Y/Y Change
Operating Cash Flow
-26.5M
↓ 22.9%
Investing Cash Flow
34.7M
↓ 122.2%
Financing Cash Flow
-33.1M
↓ 114.09%
Q3 FY22Q/Q Change
Operating Cash Flow
6.0M
↓ 193.6%
Investing Cash Flow
-2.6M
↓ 120.1%
Financing Cash Flow
-494.0K
↓ 239.94%
Q4 FY22Q/Q Change
Operating Cash Flow
-6.7M
↓ 212.26%
Investing Cash Flow
6.0M
↓ 333.04%
Financing Cash Flow
-10.5M
↑ 2017.21%
Q1 FY23Q/Q Change
Operating Cash Flow
9.5M
↓ 241.14%
Investing Cash Flow
-4.1M
↓ 168.52%
Financing Cash Flow
-3.4M
↓ 67.38%
Q2 FY23Q/Q Change
Operating Cash Flow
16.8M
↑ 77.43%
Investing Cash Flow
2.4M
↓ 157.7%
Financing Cash Flow
-2.5M
↓ 25.53%
Q3 FY23Q/Q Change
Operating Cash Flow
25.2M
↑ 49.71%
Investing Cash Flow
-31.1M
↓ 1408.93%
Financing Cash Flow
-1.6M
↓ 38.65%

Technicals Summary

Sell

Neutral

Buy

Hims & Hers Health Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Hims & Hers Health Inc
Hims & Hers Health Inc
-20.85%
102.45%
12.82%
10.7%
-19.57%
Colgate-palmolive Co.
Colgate-palmolive Co.
-1.72%
18.72%
14.84%
7.94%
25.09%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
-6.62%
-0.43%
-46.3%
-55.35%
-18.96%
Procter & Gamble Company, The
Procter & Gamble Company, The
-2.64%
4.62%
3.8%
14.9%
48.01%
Kenvue Inc.
Kenvue Inc.
-4.6%
-3.94%
-28.36%
-28.36%
-28.36%
Kimberly-clark Corp.
Kimberly-clark Corp.
1.39%
2.05%
-9.2%
-9.34%
1.95%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Hims & Hers Health Inc
Hims & Hers Health Inc
NA
NA
NA
0.05
-0.07
-0.04
NA
1.61
Colgate-palmolive Co.
Colgate-palmolive Co.
31.11
31.11
2.15
3.49
2.79
0.15
0.02
0.74
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
106.15
106.15
1.6
2.25
0.07
0.03
0.02
15.94
Procter & Gamble Company, The
Procter & Gamble Company, The
26.12
26.12
3.28
6.45
0.32
0.11
0.03
20.28
Kenvue Inc.
Kenvue Inc.
21.34
21.34
2.11
1.14
0.11
0.07
0.04
5.85
Kimberly-clark Corp.
Kimberly-clark Corp.
24.05
24.05
1.57
6.9
2.0
0.1
0.04
2.72
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Hims & Hers Health Inc
Hims & Hers Health Inc
Buy
$2.7B
-19.57%
NA
-2.7%
Colgate-palmolive Co.
Colgate-palmolive Co.
Buy
$70.8B
25.09%
31.11
11.82%
Estée Lauder Companies Inc.
Estée Lauder Companies Inc.
Buy
$49.2B
-18.96%
106.15
3.08%
Procter & Gamble Company, The
Procter & Gamble Company, The
Buy
$367.0B
48.01%
26.12
17.6%
Kenvue Inc.
Kenvue Inc.
Buy
$36.8B
-28.36%
21.34
10.77%
Kimberly-clark Corp.
Kimberly-clark Corp.
Hold
$42.2B
1.95%
24.05
8.63%

Institutional Holdings

  • Vanguard Group Inc

    6.64%

  • BlackRock Inc

    5.09%

  • Forerunner Ventures Management, LLC

    4.57%

  • Institutional Venture Management XVI, LLC

    3.62%

  • Institutional Venture Management XV, LLC

    3.62%

  • Redpoint Management, LLC

    3.55%

Corporate Announcements

  • Hims & Hers Health Inc Earnings

    Hims & Hers Health Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

hims, inc. manufactures men's wellness products. it offers products, including hair loss prevention medicines, sexual wellness products, skincare products, and oral care products. the company also provides sweaters, jackets, corduroy, sport coats, wool overcoat, leather boots, flannel, shirts, caps, and candles. it sells its products online. the company was incorporated in 2013 and is based in san francisco, california.

Organization
Hims & Hers Health Inc
Employees
1046
CEO
Mr. Andrew Dudum
Industry
Consumer Defensive

Discover More

FAQs